Objectives: To evaluate the availability of mifepristone and misoprostol at pharmacies in a state with protective abortion legislation and variation in access by rurality.
Study design: Using a secret shopper survey, researchers attempted to contact all community pharmacies in Oregon and evaluate their mifepristone and misoprostol provisions.
Results: Among the 444 pharmacies surveyed, mifepristone was planned at 19.2%. Misoprostol was available at 77.5%, but stocking issues and medication ordering impact access, without significant differences by rurality.
Conclusions: Pharmacy engagement and support are key to increasing access to these essential medicines, which may be improved through education and referral programs.
Keywords: Abortion; Mifepristone; Misoprostol; Pharmacy.
Copyright © 2024 Elsevier Inc. All rights reserved.